Cold Agglutinin Disease

Case presentation

  • 2010: p/w hemolytic anemia, eventually found to have cold agglutinin disease
  • 2010 - 2015: rituximab, multiple cycles
  • 2016: rituximab + fludarabine
  • 2018: rituximab + bortezomib
  • 2019: rituximab + bendamustine
  • 2022: sutimlimab recommended
6 / 22